112 related articles for article (PubMed ID: 22187031)
1. EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
Sesboüé R; Le Pessot F; Di Fiore F; Frebourg T
Br J Cancer; 2012 Jan; 106(2):426-7; author reply 428. PubMed ID: 22187031
[No Abstract] [Full Text] [Related]
2. EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer.
Ålgars A; Lintunen M; Carpén O; Ristamäki R; Sundström J
Br J Cancer; 2011 Jul; 105(2):255-62. PubMed ID: 21694725
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray analysis of EGFR gene amplification and gain in Bulgarian patients with colorectal cancer.
Petrova D; Jankova R; Yosifova A; Tzenova V; Dimova I; Toncheva D
Onkologie; 2006 May; 29(5):198-200. PubMed ID: 16679780
[TBL] [Abstract][Full Text] [Related]
4. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
[TBL] [Abstract][Full Text] [Related]
5. Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.
Sartore-Bianchi A; Bencardino K; Di Nicolantonio F; Pozzi F; Funaioli C; Gambi V; Arena S; Martini M; Lamba S; Cassingena A; Schiavo R; Bardelli A; Siena S
Target Oncol; 2010 Mar; 5(1):19-28. PubMed ID: 20383783
[TBL] [Abstract][Full Text] [Related]
6. [EGFR and HER2 gene expression status and their correlation in non-small cell lung cancer].
Zeng X; Wu SF; Zhou WX; Li DJ; Gao J; Liang ZY; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):398-402. PubMed ID: 17069674
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of EGFR gene copy loss in colorectal carcinomas by fluorescence in situ hybridization (FISH): a surrogate marker for sensitivity to specific anti-EGFR therapy?
Sauer T; Guren MG; Noren T; Dueland S
Histopathology; 2005 Dec; 47(6):560-4. PubMed ID: 16324192
[TBL] [Abstract][Full Text] [Related]
8. EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer.
Birkman EM; Avoranta T; Ålgars A; Korkeila E; Lintunen M; Lahtinen L; Kuopio T; Ristamäki R; Carpén O; Sundström J
Hum Pathol; 2018 Dec; 82():163-171. PubMed ID: 30096327
[TBL] [Abstract][Full Text] [Related]
9. EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis.
Yang ZY; Shen WX; Hu XF; Zheng DY; Wu XY; Huang YF; Chen JZ; Mao C; Tang JL
J Hematol Oncol; 2012 Aug; 5():52. PubMed ID: 22897982
[TBL] [Abstract][Full Text] [Related]
10. EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study.
Jacobs MS; Persons DL; Fraga GR
J Cutan Pathol; 2013 May; 40(5):447-54. PubMed ID: 23521519
[TBL] [Abstract][Full Text] [Related]
11. A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodies.
Yoshida M; Shimura T; Sato M; Ebi M; Nakazawa T; Takeyama H; Joh T
J Cancer Res Clin Oncol; 2013 Mar; 139(3):367-78. PubMed ID: 23099994
[TBL] [Abstract][Full Text] [Related]
12. EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas.
Rössle M; Weber CS; Züllig L; Graf N; Jochum W; Stöckli SJ; Moch H; Huber GF
Histopathology; 2013 Aug; 63(2):271-8. PubMed ID: 23763474
[TBL] [Abstract][Full Text] [Related]
13. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.
Lièvre A; Bachet JB; Le Corre D; Boige V; Landi B; Emile JF; Côté JF; Tomasic G; Penna C; Ducreux M; Rougier P; Penault-Llorca F; Laurent-Puig P
Cancer Res; 2006 Apr; 66(8):3992-5. PubMed ID: 16618717
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas.
Werkmeister R; Brandt B; Joos U
Oral Oncol; 2000 Jan; 36(1):100-5. PubMed ID: 10889928
[TBL] [Abstract][Full Text] [Related]
15. Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
Kendall A; Lord R; Maisey N
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):142-51. PubMed ID: 19954416
[TBL] [Abstract][Full Text] [Related]
16. Detection of HER-2 and EGFR gene amplification using chromogenic in-situ hybridization technique in ovarian tumors.
Lee ES; Lee Y; Suh D; Kang J; Kim I
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):69-74. PubMed ID: 19652593
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
[TBL] [Abstract][Full Text] [Related]
18. [Status of gene mutation and copy number of EGFR in 290 cases of non-small cell lung carcinoma].
Liang ZY; Zeng X; Zhang J; Wu SF; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):654-9. PubMed ID: 19094482
[TBL] [Abstract][Full Text] [Related]
19. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
[TBL] [Abstract][Full Text] [Related]
20. Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas.
Chiang WF; Liu SY; Yen CY; Lin CN; Chen YC; Lin SC; Chang KW
Oral Oncol; 2008 Mar; 44(3):270-6. PubMed ID: 17468034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
